Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH)

BMS-963272Cas# 1441057-15-3

Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the

Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the

Pharmacotherapies of NAFLD: updated opportunities based on

Pharmacotherapies of NAFLD: updated opportunities based on

Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated

Inhibition of Diacylglycerol Acyltransferase 2 Versus

Diseases, Free Full-Text

New Drugs on the Block—Emerging Treatments for Nonalcoholic